TIAA CREF Investment Management’s Enzo Biochem, Inc. ENZ Stock Holding History

TIAA CREF Investment Management’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	$874K	Sell	320,061 -26,350	-8%	-$86.2K	﹤0.01%	2381
2018 Q4	$963K	Sell	346,411 -103,955	-23%	-$341K	﹤0.01%	2296
2018 Q3	$1.86M	Sell	450,366 -22,309	-5%	-$101K	﹤0.01%	2156
2018 Q2	$2.45M	Sell	472,675 -203,762	-30%	-$1.24M	﹤0.01%	2058
2018 Q1	$3.71M	Buy	676,437 +24,509	+4%	+$173K	﹤0.01%	1754
2017 Q4	$5.31M	Sell	651,928 -83,627	-11%	-$799K	﹤0.01%	1568
2017 Q3	$7.7M	Buy	735,555 +201,632	+38%	+$2.24M	0.01%	1316
2017 Q2	$5.89M	Buy	533,923 +162,854	+44%	+$1.52M	﹤0.01%	1490
2017 Q1	$3.11M	Buy	371,069 +56,301	+18%	+$397K	﹤0.01%	1880
2016 Q4	$2.18M	Buy	314,768 +7,945	+3%	+$50.7K	﹤0.01%	2141
2016 Q3	$1.56K	Buy	306,823 +107,955	+54%	+$645K	﹤0.01%	2314
2016 Q2	$1.19M	Buy	+198,868	New	+$1.1M	﹤0.01%	2423
2015 Q4	–	Sell	-86,606	Closed	-$275K	–	3148
2015 Q3	$275K	Sell	86,606 -84,446	-49%	-$256K	﹤0.01%	3004
2015 Q2	$518K	Sell	171,052 -25,826	-13%	-$72.6K	﹤0.01%	2946
2015 Q1	$581K	Buy	196,878 +13,167	+7%	+$43.1K	﹤0.01%	2878
2014 Q4	$816K	Sell	183,711 -13,913	-7%	-$66.3K	﹤0.01%	2766
2014 Q3	$1.02M	Buy	197,624 +20,100	+11%	+$107K	﹤0.01%	2614
2014 Q2	$932K	Buy	+177,524	New	+$768K	﹤0.01%	2757

Other funds holding ENZ

EGA

Evermore Global Advisors Summit, New Jersey $26.3M AUM 7.42% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

HFA

Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RAM

Roumell Asset Management Chevy Chase, Maryland $53.3M AUM 8.91% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TIAA CREF Investment Management's ENZ Position: Q1 2019 in Review

TIAA CREF Investment Management reduced its Enzo Biochem, Inc. (ENZ) stake by 7.6% in Q1 2019, selling an estimated $86.2K and leaving 320,061 shares worth $874K. The position accounts for ﹤0.01% of the portfolio, ranked #2381.

TIAA CREF Investment Management first reported a position in ENZ in Q2 2014 and has held it in 18 quarters since. The position peaked at $7.7M in Q3 2017. 85 funds tracked by Wall St. Rank hold ENZ as of Q1 2019.

TIAA CREF Investment Management held 320,061 shares of Enzo Biochem, Inc. worth $874K as of Q1 2019.
TIAA CREF Investment Management sold 26,350 Enzo Biochem, Inc. shares in Q1 2019, an estimated $86.2K.
Enzo Biochem, Inc. made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2381 holding.
TIAA CREF Investment Management first reported a position in Enzo Biochem, Inc. in Q2 2014 and has held it in 18 quarters since.
TIAA CREF Investment Management's Enzo Biochem, Inc. position peaked at $7.7M in Q3 2017.
85 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.